FindTrial
Sign In

A study to compare efficacy of oral terbinafine and I.P.L.(Intense Pulsed Light)v/s oral terbinafine alone in resistant tinea

The comparative study of efficacy of oral terbinafine and I.P.L.(Intense Pulsed Light)v/s oral terbinafine alone in patients difficult to treat tinea

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/016867
Enrollment
80
Registered
2019-01-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: tab.terbinafine 250mg: tab.terbinafine 250mg 1BD is to be given for total period of 2 months Control Intervention1: Intense pulsed light: It is to be given once in a 2 week for total pe

Sponsors

MGM Medical college and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)All patients of difficult to treat tinea. 2)Only those patients who have at least 5 patches are selected. 3)Age: have completed 18 years of age 4)Belonging to either sex. males or females

Exclusion criteria

Exclusion criteria: 1)Patient with hypersensitivity to drug or patient intolerant to the study medication. 2)Patients of tinea cruris,onychomycosis 3)Pregnancy 4)Breastfeeding 5)At the site of active skin infection. e.g.impetigo or herpes simplex 6)Previous experience of photosensitivity/sun allergies

Design outcomes

Primary

MeasureTime frame
To study the efficacy of Oral Terbinafine and I.P.L.(Intense Pulsed Light)v/s Oral Terbinafine alone.Timepoint: Every 2 weeks for 2 months then follow up every 1 month for next 3 months—

Secondary

MeasureTime frame
To study adverse effect of Intense Pulsed Light and Oral Terbinafine.Timepoint: Every 2 weeks for 2 months then follow up every 1 month for next 3 months—

Countries

India

Contacts

Public ContactDrSuraj pawar

Mahatma Gandhi Missions Medical College and Hospital

ashish7557@gmail.com9422213292

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026